127 related articles for article (PubMed ID: 19195624)
1. Definition and natural history of metabolic steatosis: histology and cellular aspects.
Paradis V; Bedossa P
Diabetes Metab; 2008 Dec; 34(6 Pt 2):638-42. PubMed ID: 19195624
[TBL] [Abstract][Full Text] [Related]
2. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L; Lemoine M
Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
[TBL] [Abstract][Full Text] [Related]
3. Pathologic assessment of non-alcoholic fatty liver disease.
Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of histological features in non-alcoholic fatty liver disease.
Vasdev N; Kakati AG; Saigal S; Nayak NC
Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
[TBL] [Abstract][Full Text] [Related]
5. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
Mendler MH; Kanel G; Govindarajan S
Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
[TBL] [Abstract][Full Text] [Related]
6. Histological assessment of non-alcoholic fatty liver disease.
Hübscher SG
Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
8. The role of the lipogenic pathway in the development of hepatic steatosis.
Postic C; Girard J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
10. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.
Lima ML; Mourão SC; Diniz MT; Leite VH
Obes Surg; 2005 May; 15(5):661-9. PubMed ID: 15946458
[TBL] [Abstract][Full Text] [Related]
11. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease.
Hjelkrem MC; Torres DM; Harrison SA
Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and natural history of NAFLD and NASH.
Ong JP; Younossi ZM
Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease: the mist gradually clears.
de Alwis NM; Day CP
J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
[TBL] [Abstract][Full Text] [Related]
15. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
Sevastianos VA; Hadziyannis SJ
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis].
Alvarez-Martínez HE; Montaño-Estrada LF; Hernández-Cruz P; Pérez-Campos E
Rev Gastroenterol Mex; 2004; 69(3):176-83. PubMed ID: 15759791
[TBL] [Abstract][Full Text] [Related]
18. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
Ekstedt M; Franzén LE; Mathiesen UL; Holmqvist M; Bodemar G; Kechagias S
J Hepatol; 2007 Jul; 47(1):135-41. PubMed ID: 17400325
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in nonalcholic fatty liver disease.
Greenfield V; Cheung O; Sanyal AJ
Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
[TBL] [Abstract][Full Text] [Related]
20. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
